In ovarian-related cancers, the plasma concentration in 46 samples of patients with ovarian cancer and 61 controls were tested for the immunoreactivity of AGR2, and the results revealed significantly high levels of AGR2 in the cancer cases [55]. The gene discussed is AGR2; the disease is ovarian cancer.